SCHEMBL8273965

SCHEMBL8273965

Clc1ccc2[nH]c([C@@H]3CCCN3)nc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN10A Q9Y5Y9 1/20 0.55
▸ CDC7 O00311 5/20 0.50
▸ PIM1 P11309 3/20 0.50
▸ CSNK2B P67870 3/20 0.50
▸ CSNK2A1 P68400 3/20 0.50
▸ CIT O14578 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CSNK2A2 P19784 1/20 0.50
▸ GSK3B P49841 1/20 0.50
▸ DYRK1A Q13627 1/20 0.50
▸ CSNK2A3 Q8NEV1 1/20 0.50
▸ TAOK3 Q9H2K8 1/20 0.50
▸ PARP1 P09874 6/20 0.44
▸ CCNE1 P24864 2/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ ROCK1 Q13464 2/20 0.38
▸ DBF4 Q9UBU7 2/20 0.38
▸ HRH4 Q9H3N8 3/20 0.38
▸ RIPK1 Q13546 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4956569 0.88 SCN10A (0.48) SCN10ACDC7PIM1CSNK2BCSNK2A1
SCHEMBL12509313 0.85 SCN10A (0.58) SCN10ACDC7PIM1CSNK2BCSNK2A1
SCHEMBL9605019 0.84 SCN10A (0.56) SCN10ACDC7PIM1CSNK2BCSNK2A1
SCHEMBL1645792 0.84 SCN10A (0.56) SCN10ACDC7PIM1CSNK2BCSNK2A1
SCHEMBL12684295 0.83 SCN10A (0.59) SCN10ACDC7DYRK1APARP1CCNE1
SCHEMBL15452944 0.83 SCN10A (0.55) SCN10ACDC7PIM1CSNK2BCSNK2A1
SCHEMBL10153356 0.83 SCN10A (0.55) SCN10ACDC7PIM1CSNK2BCSNK2A1
SCHEMBL19488467 0.83 SCN10A (0.59) SCN10ACDC7DYRK1APARP1CCNE1
Hydrochloric Acid SCHEMBL1646698 0.83 SCN10A (0.55) SCN10ACDC7PIM1CSNK2BCSNK2A1
SCHEMBL12098828 0.83 SCN10A (0.55) SCN10ACDC7PIM1CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080015146-A1 Dpp-IV Inhibitors SANTHERA PHARMACEUTICALS (DEUTSCHLAND) AG (DE) 2008-01-17 — — US disclosed
US-20080015146-A1 Dpp-IV Inhibitors SANTHERA PHARMACEUTICALS (DEUTSCHLAND) AG (DE) 2008-01-17 — — US disclosed
WO-2005121131-A1 DPP-IV INHIBITORS SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) 2005-12-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015146-A1 Dpp-IV Inhibitors DPP4, DPP9, DPP3 SCN10A 803/4885CDC7 4318/4885PIM1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback